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Background: Despite significant improvements in cardiac output and functional capacity with cardiac
resynchronization therapy (CRT), incidence of sudden cardiac death still remains high. Reversal
of physiological myocardial activation sequence during epicardial pacing increases the transmural
dispersion of repolarization (TDR). The aim of this study was to compare the effects of endocardial
and epicardial biventricular pacing on repolarization parameters in the same patient group.
Methods: Seven patients who had transseptal endocardial left ventricle (LV) lead placement, in whom
epicardial CRT had failed due to coronary sinus (CS) lead dislodgement after successful implantation,
were admitted to the study. LV endocardial leadswere implanted through the interatrial septum in a lateral
position. Electrocardiograms (ECGs) were scanned before and after successful epicardial and endocardial
biventricular pacing and analyzed using digital calipers. ECG markers of TDR (TpTe and TpTe/QT ratio)
were measured and compared.
Results: Baseline QRS durations (161.7 ± 15.9 ms vs 162.2 ± 17.8 ms, P = 0.95), TpTe values (107.1 ±
20.5 ms vs 108.5 ± 17.6 ms, P = 0.89), and TpTe/QT ratios (0.24 ± 0.05 vs 0.24 ± 0.03, P = 0.88) were
similar before epicardial and endocardial CRT. QRS interval reduction was similar (–28.3 ± 11.6 ms vs
–29.1 ± 11.4 ms, P = 0.89) in both groups. Compared to transseptal endocardial CRT, epicardial CRT was
associated with a significant increase in TpTe (17.1 ± 19.5 ms vs –12.6 ± 18.9 ms, P = 0.01) and TpTe/QT
ratio (0.03 ± 0.04 vs –0.02 ± 0.03, P = 0.04).
Conclusion: Transseptal LV endocardial pacing is associated with significant reduction in TDR
characteristics compared to epicardial pacing in CRT. Further studies are warranted to determine whether
these effects may contribute to reduction of arrhythmias in patients with CRT. (PACE 2015; 0:1–7)
cardiac resynchronization therapy, transmural dispersion of repolarization, transseptal endocardial
biventricular pacing, heart failure, ventricular arrhythmias
Introduction
Despite all the advances in pharmacological
treatment, heart failure (HF) remains a leading
cause of morbidity and mortality.1–3 For this
reason, cardiac resynchronization therapy (CRT)
is an important therapeutic option in the man-
agement of patients with symptomatic systolic
HF.4,5 Biventricular pacing significantly improves
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cardiac output, quality of life, and functional
capacity in patients with congestive HF. However,
the incidence of sudden cardiac death still remains
high.6 Recent studies have shown that reversal of
the normal myocardial activation sequence during
epicardial pacing, as it occurs during conven-
tional CRT, increases the transmural dispersion
of repolarization (TDR).7,8 Biventricular pacing
or left ventricular (LV) epicardial pacing may
increase the QT interval and TDR, which have
the potential to increase the risk of ventricular
arrhythmias.8–10 Increased TDR as measured by
Tpeak-Tend (TpTe) and TpTe/QT is found to be
associated with a higher incidence of ventricular
arrhythmias in cardiac resynchronization therapy
with defibrillator (CRT-D) patients.11 Although
large multicenter randomized studies have not
reported any increased incidence of ventricular
tachycardia (VT) or ventricular fibrillation (VF)
© 2015 Wiley Periodicals, Inc.
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episodes, it is important to determine CRTpatients
who are prone to have ventricular arrhythmias.4,6
CRT with transseptal endocardial LV pacing
is an alternative in patients where the con-
ventional approach has failed.12,13 Endocardial
pacing also leads to more physiological activation.
Experimental observations suggest that potential
arrhythmias can be avoided by stimulation of
the LV endocardium.9 A recently published
small case control study suggests that permanent
biventricular pacing with LV endocardial lead
placement through the interatrial septum is
associated with significantly lower TpTe and
QT dispersion values compared to control group
with a coronary sinus (CS) LV lead.14 This
small observational study with a case control
design provides crucial information. However,
finding a perfect match between small patient
groups is not always possible and differences
in baseline characteristics between groups may
have an impact on results. The aim of this study
was to compare the effects of endocardial and
epicardial biventricular pacing on repolarization
characteristics in the same patient group.
Methods
Patient Population
All patients suitable for transseptal endo-
cardial LV lead placement, in whom epicardial
CRT had failed due to lead dislodgement after
successful CS implantation, were admitted to the
study. All patients included were required to meet
European Society of Cardiology Class I criteria for
CRT implantation.4 After successful transseptal
CRT implantation, all patients’ hospital recordings
were evaluated. Patients who had previous suc-
cessful conventional CRT implantation were se-
lected. Electrocardiograms (ECGs) were recorded
before and after successful conventional CRT, as
were location of CS leads and pacing threshold
values.
Endocardial LV Lead Implantation
Procedures started with transseptal puncture
from the femoral vein, under guidance of intrac-
ardiac echocardiography. The puncture site was
dilated with an 8-mm angioplasty balloon, and the
guidewire was left across the septum as a marker.
Subsequently, a guidewire was passed through
the same hole inserted from the subclavian vein
through a guiding catheter produced for CS lead
implantation. Once the guiding catheter was
advanced to the left atrium, its tip was directed
to the mitral valve and an active fixation lead was
implanted in the lateral area of the LV. All patients
were maintained on anticoagulation therapy with
either warfarin or coumarin.
Electrocardiographic Measurements
ECGs (25mm/s, 10 mm/mV) were recorded on
admission (preendocardial CRT ECG [pre-endo-
CRT ECG]) and before discharge (postendocardial
CRT ECG [post-endo-CRT ECG]) after successful
LV endocardial lead implantation. The ECGs of the
same patients before and after successful CRTwith
CS epicardial pacing were found from hospital
records. These ECGs were defined as preepicardial
CRT (pre-epi-CRT) and postepicardial CRT (post-
epi-CRT) ECGs. All ECGs were digitally scanned
andmeasurementsweremadewith digital calipers
at 400% magnification. Analysis was performed
by a blinded physician. Lead V5 was selected for
analysis. If the T wave in V5 was not eligible,
lead II was used. The QT interval was defined as
the time interval between the initial deflection of
the QRS and the point at which a tangent drawn
on the steepest downslope of the T wave crossed
the isoelectric line.15 Intervals were corrected
for heart rate using Bazett’s formula.16 The TpTe
interval was obtained from the difference between
the QT interval and the QT peak interval. The QT
peak interval was measured from the beginning of
the QRS until the peak of a positive T wave or the
nadir of a negative T wave.17 The TpTe/QT ratio
was also calculated. Patients were on the same
medications during measurements and none of
them had anesthesia during procedures.
Statistics
Mean and standard deviations (SD) were
used for descriptive statistics. Categorical data
were summarized as frequencies and percentages.
Comparisons of repolarization parameters
between pacing modes (baseline, epi-CRT, endo-
CRT) were performed with paired two-tailed
Student t-tests. In all analyses, P < 0.05 was
considered statistically significant.
Results
Between September 2007 and March 2014, 48
patients in our center had transseptal endocardial
LV lead placement. Thirteen of them had a
CS lead dislodgement history after successful
conventional CRT implantation and epicardial
pacing. Five patients who did not have analyzable
CRT ECGs and one patient who had CRT upgrade
from RV pacing were excluded. Therefore, seven
patients were included. No patient was excluded
due to uncontrolled heart rate (biventricular
pacing rate <90%), procedure-related compli-
cations, or death. Baseline characteristics are
given in Table I. The mean age of the patients
was 63 ± 4 years and the majority of them
were male. Four (57.1%) had ischemic dilated
cardiomyopathy. The positions of the CS leads
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Table I.
Baseline Characteristics of Study Patients
Age (years) 63 ± 3.7
Male 6 (85.7)
LVEF (%) 30 ± 3.0
Etiology
Ischemic 4 (57.1)
Nonischemic 3 (42.9)
NYHA functional class
II 1 (14.3)
III 6 (85.7)
Device
CRT-D 4 (57.1)
CRT-P 3 (42.9)
AF 2 (28.6)
DM 1 (14.3)
HT 5 (71.4)
Hg (g/dL) 14.4 ± 1.4
Cr (µmol/L) 89.2 ± 14.6
Drugs
ACE-I/ARB 7 (100)
β-Blocker 5 (71.4)
Amiodarone 1 (14.3)
Other QT prolonging drug 0
QRS morphology (LBBB) 7 (100)
Values are mean ± SD or n (%).
ACE-I = angiotensin-converting enzyme inhibitor; AF = atrial
fibrillation; ARB = angiotensin II receptor blocker; CRT-D =
cardiac resynchronization therapy with defibrillator; CRT-P =
cardiac resynchronization therapy pacemaker; DM = diabetes
mellitus; HT = hypertension; LBBB = left bundle branch block;
LVEF = left ventricle ejection fraction; NYHA = New York Heart
Association.
were reported in a lateral location with stable
pacing thresholds. Transseptal LV leads were
implanted in lateral position in all patients. Mean
elapsed time between the initial epicardial CRT
and endocardial CRT was 10.5 ± 8.9 months.
No thromboembolic complications were observed
during the follow-up.
Baseline QRS durations (161.7 ± 15.9 ms vs
162.2 ± 17.8 ms, P = 0.95), QTc intervals (435.6 ±
56.9 ms vs 444.6 ± 44.5 ms, P = 0.73), TpTe
values (107.1 ± 20.5 ms vs 108.5 ± 17.6 ms, P =
0.89), and TpTe/QT ratios (0.24 ± 0.05 vs 0.24 ±
0.03, P = 0.88) were similar before epi- and
endo-CRT (Table II).
In all patients, QRS intervals reduced
significantly following both epi- and endo-CRT
(161.71 ± 16 ms vs 133.42 ± 15 ms, P < 0.01;
162.28 ± 18 ms vs 133.14 ± 8 ms, P < 0.01,
respectively). Although QRS interval reductions
were similar (–28.3 ± 11.6 ms vs –29.1 ± 11.4 ms,
P = 0.89), epi-CRT was associated with a
Table II.
Comparison of Repolarization Parameters before and
after Cardiac Resynchronization Therapy with
Endocardial and Epicardial Left Ventricular Pacing
Epicardial Endocardial P Value
Baseline QRS 161.7 ± 15.9 162.2 ± 17.8 0.95
Baseline QTc 435.6 ± 56.9 444.6 ± 44.5 0.73
Baseline
Tp-Te
107.1 ± 20.5 108.5 ± 17.6 0.89
Baseline
Tp-Te/QT
0.24 ± 0.05 0.24 ± 0.03 0.88
Post CRT
Tp-Te
124.3 ± 30.8 96.0 ± 27.1 0.09
Post CRT
Tp-Te/QT
0.27 ± 0.05 0.22 ± 0.04 0.08
"QRS −28.3 ± 11.6 −29.1 ± 11.4 0.89
"QTc 14.4 ± 37.5 −17.0 ± 45.2 0.19
"Tp-Te 17.1 ± 19.5 −12.6 ± 18.9 0.01
"Tp-Te/QT 0.03 ± 0.04 −0.02 ± 0.03 0.04
TpTe = Tpeak-Tend.
significant increase in TpTe values (17.1 ± 19.5
ms vs –12.6 ± 18.9 ms, P = 0.01) and TpTe/QT
ratios (0.03 ± 0.04 vs –0.02 ± 0.03, P = 0.04)
compared to endo-CRT (Fig. 1). Differences in
QTc interval changes were not significant (14.4 ±
37.5 ms vs –17.0 ± 45.2 ms, P = 0.19; Table II). RR
intervals were similar before and after, epi- and
endo-CRT (pre-epi vs pre-endo, 797.14 ± 55 ms vs
806.00 ± 45 ms, P = 0.85, post-epi vs post-endo,
781.12 ± 73 ms vs 786.24 ± 46 ms, P = 0.87).
Discussion
The main findings of this study suggest that
permanent LV endocardial CRT is associated
with significant reduction in TDR characteris-
tics compared to conventional epicardial CRT.
Nonphysiological activation of both ventricles
with different transmural activation sequences
might be responsible for an increase in TDR
during epicardial CRT. Our study is the first to
compare the effects of permanent endocardial
and epicardial CRT in the same patient group.
The effect of stimulating both sides of the same
substrate (the lateral wall of the LV)was evaluated.
It has been shown that even in the absence
of any difference in final repolarization time,
reversing the direction of activation affects the
action potential curve and T-wave morphology.8,9
Medina-Ravell et al. evaluated pacing site depen-
dent changes in ventricular repolarization, and
observed more significant prolongation in TDR
with epicardial and biventricular pacing.7 They
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Figure 1. Box plot of change in TpTe following epicardial and endocardial cardiac resynchronization therapy.
CRT = cardiac resynchronization therapy; endo = endocardial; epi = epicardial; TpTe = Tpeak-Tend.
reported the development of torsades de pointes
in a HF patient with epicardial or biventricular
pacing, but not with endocardial pacing only.
Monomorphic ventricular tachycardias induced
by CRT are also reported.18,19
Despite of the few case reports, none of the
large multicenter randomized trials have reported
an increased risk of ventricular arrhythmias
with CRT.20–24 Higgins et al. observed less im-
plantable cardioverter defibrillator (ICD) therapy
with CRT compared to no pacing.20 A meta-
analysis of randomized trials of CRT also found
no relation between sudden cardiac death and
CRT.21 Kutyifa et al. analyzed the association
between the LV lead location and the risk of
ventricular arrhythmias in patients enrolled in the
Multicenter Automatic Defibrillator Implantation
Trial with Cardiac Resynchronization Therapy
(MADIT-CRT) trial.22 Posterior and lateral LV lead
location was associated with decreased risk of
ventricular arrhythmias in comparison with an
anterior lead location or ICD-only group.
These results raise concern that CRT might
have a differential effect on different substrates
and also pacing site might have an impact.23
Recently, Scott et al. investigated the effect
of permanent endocardial CRT on ventricular
repolarization in humans.14 They evaluated seven
patients with transseptal LV endocardial leads,
28 matched patients with CS LV leads, and
eight patients with surgical LV epicardial leads.
Significant postpacing reduction in TpTe and QT
dispersion values were observed in the transseptal
group compared to the CS group. However,
this case control designed study had limitations
due to the difficulty of finding a perfect match
between the groups. Although our observations
on repolarization patterns were consistent with
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Figure 2. The effects of epicardial and endocardial cardiac resynchronization therapy (CRT) on QRS (A) and
TpTe (B) in the same patient group. Please note that epicardial and endocardial CRT produced similar QRS
interval reductions. However, epicardial CRT was associated with a significant increase in TpTe values compared to
endocardial CRT. post-endo= postendocardial CRT; post-epi= postepicardial CRT; pre-endo= preendocardial CRT;
pre-epi = preepicardial CRT; TpTe = Tpeak-Tend.
Scott et al., we observed different depolarization
changes. They reported significantly better post-
CRT reduction in QRS duration in the transseptal
group. However, we observed similar QRS reduc-
tion with epi- and endo-CRT in the same patient
group.
The QRS interval during biventricular pacing
is complicated because there are two activation
vectors. The underlying heart disease and localiza-
tions of myocardial scars can make a contribution
to the electrophysiological effects of biventricular
pacing. Therefore, differences between the LV
endocardial patients and the control group might
be responsible for this finding.
Factors that influence depolarization patterns
may also affect repolarization patterns. Neverthe-
less, our results corroborate animal experiments
which evaluated the effects of endocardial
and epicardial pacing on transmural wedge
preparations.7,25 Despite a similar reduction in
QRS intervals, we observed significant changes
in TpTe and TpTe/QT values (Fig. 2). QTc and
TpTe values were increased with epi-CRT and
decreased with endo-CRT. Therefore, the main
differential effect of endocardial CRT seems to be
on repolarization rather than to depolarization.
A TpTe/QT ratio of ≥ 0.25 is reported as
a significant risk factor for appropriate ICD
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therapy in conventional CRT-D patients.11 In
our patient group, baseline TpTe/QT ratios were
similar for both epi- and endo-CRT. However,
mean TpTe/QT ratios increased to 0.27 ± 0.05
with epi-CRT and decreased to 0.22 ± 0.04 with
endo-CRT. !TpTe/QT values were significantly
different (Table II).
However, in two patients different responses
were observed (Fig. 2). In patient 3, TpTe values
were decreased both after epicardial and endocar-
dial CRT. Contrarily, patient 6 demonstrated TpTe
increase with both epicardial and endocardial
CRT. Patient 3 had nonishemic cardiomyopathy
and relatively better ejection fraction (33%).
Patient 6 had ischemic cardiomyopathy with
large anterior scar and ejection fraction was 27%.
Although LV was stimulated in the same region
but opposite sites, the presence of ischemic scars
and heterogeneity of the myocardial substrate may
lead to changes in conduction vectors and may
change the transmural repolarization sequence.
Impact of epicardial pacing on heterogenous
myocardium is more prominent and electrical
heterogeneity is amplifiedwhen normal activation
of ventricular wall is reversed.8 Unfortunately,
due to the relatively small number of patients, no
subgroup analysis on ischemic and nonischemic
patients was performed.
LV pacing region and pacing rate might have
an impact on TDR. Both epicardial and endocar-
dial leads were implanted in the lateral region of
the LV and RR intervals were similar during mea-
surements. Another factor that may influence the
TDR is the interventricular (VV) pacing delay. In
our study, VV timing intervals were optimized to
achieve best QRS duration. Therefore, VV timing
intervals were not uniform across the patient pop-
ulation. However, this is an accepted CRT opti-
mization algorithm and reflects the daily practice.
Our study focused on TDR response during
epi- and endo-CRT, and was neither designed
nor powered to evaluate the relevant clinical
arrhythmias. Our patient group was too small to
demonstrate a significant difference in terms of
relevant clinical arrhythmias. It is important to
stress that our findings reflecting the effects of
endocardial CRT on repolarization do not suggest
that epicardial CRT is proarrhythmic.
Limitations
Although our study was limited by the small
sample size, it was sufficient to show significant
changes in TDR parameters during endo- and
epi-CRT in a uniform pattern. However, further
multicenter studies with larger patient groups are
warranted to confirm these findings.
We selected only lead V5 for repolarization
parameter measurements. Analysis of a single
lead might influence the accuracy of ventricular
repolarization. However, previous clinical studies
that showed the association of increased TpTe
interval and TpTe/QT ratio and ventricular
arrhythmias during CRT also used same measure-
ment technique, and these parameters are widely
accepted.11,26,27
In addition, only acute responses to CRT were
examined in our study, but long-term electrical
and mechanical remodeling could modify the
results.10,28,29
Conclusion
Transseptal LV endocardial pacing is asso-
ciated with significant reduction in TDR charac-
teristics compared to epicardial pacing in CRT.
Larger clinical studies are needed to determine
whether these effects may contribute to reduction
of arrhythmias.
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